Y-Intercept (HK)’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Buy
16,865
+4,472
+36% +$70.5K 0.01% 1467
2026
Q1
$178K Sell
12,393
-206,062
-94% -$3.42M ﹤0.01% 1444
2025
Q4
$3.85M Buy
+218,455
New +$3.61M 0.09% 318
2024
Q1
Sell
-19,284
Closed -$325K 1722
2023
Q4
$325K Buy
+19,284
New +$273K 0.03% 786
2023
Q3
Sell
-20,189
Closed -$380K 1536
2023
Q2
$380K Buy
+20,189
New +$321K 0.04% 682

Other funds holding SHC

Y-Intercept (HK)'s SHC Position: Q2 2026 in Review

Y-Intercept (HK) increased its Sotera Health (SHC) stake by 36% in Q2 2026, buying an estimated $70.5K and bringing the position to 16,865 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #1467.

Y-Intercept (HK) first reported a position in SHC in Q2 2023 and has held it in 5 quarters since. The position peaked at $3.85M in Q4 2025. 39 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Y-Intercept (HK) held 16,865 shares of Sotera Health worth $299K as of Q2 2026.
  • Y-Intercept (HK) bought 4,472 Sotera Health shares in Q2 2026, an estimated $70.5K.
  • Sotera Health made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1467 holding.
  • Y-Intercept (HK) first reported a position in Sotera Health in Q2 2023 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Sotera Health position peaked at $3.85M in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.